UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes
- 1 November 1997
- journal article
- other
- Published by Elsevier BV in The Lancet
- Vol. 350 (9087), 1288-1293
- https://doi.org/10.1016/s0140-6736(97)03062-6
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- GAD Antibodies in NIDDM: Ten-year follow-up from the diagnosisDiabetes Care, 1995
- Glutamate decarboxylase antibody levels predict rate of β-cell decline in adult-onset diabetesDiabetes Research and Clinical Practice, 1995
- Latent Autoimmune Diabetes Mellitus in Adults (LADA): the Role of Antibodies to Glutamic Acid Decarboxylase in Diagnosis and Prediction of Insulin DependencyDiabetic Medicine, 1994
- Immunogenetic and Clinical Characterization of Slowly Progressive IDDMDiabetes Care, 1993
- Diabetes in the United Kingdom: a Personal SeriesDiabetic Medicine, 1991
- A Prospective Study of the Development of Diabetes in Relatives of Patients with Insulin-Dependent DiabetesThe New England Journal of Medicine, 1990
- Quantification of islet-cell antibodies and prediction of insulin-dependent diabetesThe Lancet, 1990
- Epidemiologic Approach to the Etiology of Type I Diabetes Mellitus and Its ComplicationsThe New England Journal of Medicine, 1987
- CLINICAL AND PATHOGENIC SIGNIFICANCE OF PANCREATIC-ISLET-CELL ANTIBODIES IN DIABETICS TREATED WITH ORAL HYPOGLYCÆMIC AGENTSThe Lancet, 1977
- ISLET-CELL ANTIBODIES IN DIABETES MELLITUS WITH AUTOIMMUNE POLYENDOCRINE DEFICIENCIESThe Lancet, 1974